BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
54 results:

  • 1. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
    Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Efficacy analysis of hepatic arterial infusion chemotherapy combined with targeted and immune therapy followed by
    Wang M; Zhou ZG; Lu TY; Du KP; Li S; Gao F; Li YD; Gao MY
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(4):290-296. PubMed ID: 38246774
    [No Abstract]    [Full Text] [Related]  

  • 3. Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/cdk6 axis.
    Nokkeaw A; Thamjamrassri P; Chantaravisoot N; Tangkijvanich P; Ariyachet C
    Oncol Res; 2023; 31(6):989-1005. PubMed ID: 37744274
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway.
    Peng BY; Singh AK; Chan CH; Deng YH; Li PY; Su CW; Wu CY; Deng WP
    BMC Cancer; 2023 Jan; 23(1):1. PubMed ID: 36597025
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric cancer.
    Peng K; Zhang F; Wang Y; Sahgal P; Li T; Zhou J; Liang X; Zhang Y; Sethi N; Liu T; Zhang H; Bass AJ
    Clin Cancer Res; 2023 Jan; 29(1):197-208. PubMed ID: 36278961
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
    Tong H; Liu X; Peng C; Shen B; Zhu Z
    Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.
    Liu S; Zheng Q; Zhang R; Li T; Zhan J
    Pediatr Surg Int; 2022 Dec; 38(12):2023-2034. PubMed ID: 36271952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Isoginkgetin, a potential cdk6 inhibitor, suppresses
    Yao J; Tang S; Shi C; Lin Y; Ge L; Chen Q; Ou B; Liu D; Miao Y; Xie Q; Tang X; Fei J; Yang G; Tian J; Zeng X
    Autophagy; 2023 Apr; 19(4):1221-1238. PubMed ID: 36048765
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/cdk6-cyclin D1 and CXCR4/RhoA pathways.
    Zhao M; Wang Y; Zhang Y; Li X; Mi J; Wang Q; Geng Z; Zuo L; Song X; Ge S; Zhang Z; Tang M; Li H; Wang Z; Jiang C; Su F
    BMC Gastroenterol; 2022 Aug; 22(1):378. PubMed ID: 35941537
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
    Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
    Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
    Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma.
    Ma F; Huang J; Li W; Li P; Liu M; Xue H
    Environ Toxicol; 2022 Jul; 37(7):1675-1685. PubMed ID: 35286011
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human liver cancer Cells.
    Chen C; Wang YS; Zhang ET; Li GA; Liu WY; Li Y; Jin YH
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884975
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target.
    Lohoff FW; Clarke TK; Kaminsky ZA; Walker RM; Bermingham ML; Jung J; Morris SW; Rosoff D; Campbell A; Barbu M; Charlet K; Adams M; Lee J; Howard DM; O'Connell EM; Whalley H; Porteous DJ; McIntosh AM; Evans KL
    Mol Psychiatry; 2022 Mar; 27(3):1754-1764. PubMed ID: 34857913
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.
    Dang F; Nie L; Zhou J; Shimizu K; Chu C; Wu Z; Fassl A; Ke S; Wang Y; Zhang J; Zhang T; Tu Z; Inuzuka H; Sicinski P; Bass AJ; Wei W
    Nat Commun; 2021 Sep; 12(1):5386. PubMed ID: 34508104
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Upregulation of miR-124-3p by liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and cdk6.
    Zhong D; Lyu X; Fu X; Xie P; Liu M; He F; Huang G
    Technol Cancer Res Treat; 2020; 19():1533033820967473. PubMed ID: 33073697
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Induction of cell cycle arrest and apoptosis by tomentosin in hepatocellular carcinoma HepG2 and Huh7 cells.
    Yu SH; Lee CM; Ha SH; Lee J; Jang KY; Park SH
    Hum Exp Toxicol; 2021 Feb; 40(2):231-244. PubMed ID: 32787465
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma.
    Wang D; Xu Y; Goldstein JB; Ye K; Hu X; Xiao L; Li L; Chang L; Guan Y; Long G; He Q; Yi X; Zhang J; Wang Z; Xia X; Zhou L
    Liver Int; 2020 Aug; 40(8):1997-2007. PubMed ID: 32279416
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical, immunological features and follow up of 20 patients with dedicator of cytokinesis 8 (DOCK8) deficiency.
    Haskologlu S; Kostel Bal S; Islamoglu C; Aytekin C; Guner S; Sevinc S; Keles S; Kendirli T; Ceylaner S; Dogu F; Ikinciogullari A
    Pediatr Allergy Immunol; 2020 Jul; 31(5):515-527. PubMed ID: 32108967
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data.
    Yen YH; Chen CH; Hung CH; Wang JH; Lu SN; Kee KM; Hu TH
    PLoS One; 2019; 14(10):e0222605. PubMed ID: 31581209
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.